Bayer Aktienges ADR (BAYRY)
N/A x N/A N/A x N/A
Pre-market by (Cboe BZX)
6.6000 +0.0300 (+0.46%) 04/29/25 [OTC US]
N/A x N/A N/A x N/A
Pre-market 6.6000 unch (unch) 15:59 ET
for Tue, Apr 29th, 2025
Results
download Want to compare other data? Select Fields| Symbol | BAYRY | PFE | INVA | ||
| Company | Bayer Aktienges ADR | Pfizer Inc | Innoviva Inc | ||
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | ||
| Open | 6.6500 | 22.83 | 18.34 | ||
| High | 6.6500 | 24.12 | 18.75 | ||
| Low | 6.5500 | 22.46 | 18.20 | ||
| Last | 6.6000 | 23.79 | 18.52 | ||
| Change | +0.0300 | +0.74 | +0.14 | ||
| % Change | +0.46% | +3.21% | +0.76% | ||
| Volume | 173,100 | 98,540,094 | 573,200 | ||
| 20-Day Average Volume | 645,670 | 58,099,461 | 863,290 | ||
| Previous Close | 6.5700 | 23.05 | 18.38 | ||
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 5.9870 | 22.76 | 17.98 | ||
| 20-Day Raw Stochastic | 96.30% | 64.90% | 88.94% | ||
| 20-Day Relative Strength | 60.82% | 49.35% | 59.68% | ||
| Weighted Alpha | -7.57 | -17.57 | +16.40 | ||
| Today's Opinion | 40% Buy | 88% Sell | 16% Sell | ||
| Previous Opinion | 40% Buy | 88% Sell | 24% Sell | ||
| Last Month's Opinion | 16% Sell | 100% Sell | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.97% since 04/22/25 | +5.59% since 04/22/25 | +0.11% since 04/22/25 | ||
| Low | 6.2300 on 04/23/25 | 22.23 on 04/24/25 | 18.01 on 04/25/25 | ||
| High | 6.6500 on 04/29/25 | 24.12 on 04/29/25 | 18.75 on 04/29/25 | ||
| 1-Month | |||||
| %Chg | +7.43% since 03/28/25 | -5.63% since 03/28/25 | +1.87% since 03/28/25 | ||
| Low | 5.3000 on 04/07/25 | 20.92 on 04/09/25 | 16.67 on 04/10/25 | ||
| High | 6.6500 on 04/29/25 | 25.42 on 03/31/25 | 18.75 on 04/29/25 | ||
| 3-Month | |||||
| %Chg | +16.61% since 01/29/25 | -10.63% since 01/29/25 | -1.96% since 01/29/25 | ||
| Low | 5.3000 on 04/07/25 | 20.92 on 04/09/25 | 16.67 on 04/10/25 | ||
| High | 6.8300 on 03/18/25 | 27.24 on 03/10/25 | 19.06 on 01/30/25 | ||
| 6-Month | |||||
| %Chg | -5.04% since 10/29/24 | -16.41% since 10/29/24 | -6.89% since 10/29/24 | ||
| Low | 4.7900 on 12/24/24 | 20.92 on 04/09/25 | 16.67 on 04/10/25 | ||
| High | 6.8700 on 11/01/24 | 28.64 on 10/31/24 | 21.28 on 11/12/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 25,935,992 | 134,923,920 | 1,160,759 | ||
| Shares Outstanding, K | 3,929,696 | 5,671,455 | 62,676 | ||
| Annual Sales | 50,432,350,000 | 63,627,000,000 | 358,710,000 | ||
| Annual Net Income | -2,761,520,000 | 8,031,000,000 | 23,390,000 | ||
| Last Quarter Sales | 12,633,600,000 | 17,763,000,000 | 91,810,000 | ||
| Last Quarter Net Income | 1,698,820,000 | 410,000,000 | 20,330,000 | ||
| 60-Month Beta | 0.93 | 0.67 | 0.48 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.28 on 03/05/25 | 0.92 on 04/29/25 | 0.57 on 02/26/25 | ||
| Latest Earnings Date | 05/13/25 | 04/29/25 | 05/14/25 | ||
| Most Recent Dividend | 0.022 on 04/29/25 | 0.430 on 01/24/25 | 0.250 on 09/08/15 | ||
| Next Ex-Dividends Date | 04/29/25 | 05/09/25 | 09/08/15 | ||
| Ratios | |||||
| Price/Earnings ttm | 4.80 | 7.41 | 10.62 | ||